Recent News

• 03.19.2025 - Stifel 2025 Virtual CNS Forum
• 03.17.2025 - UBS Virtual CNS Day 2025
• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Ionis and Ono announce global license agreement for sapablursen in polycythemia vera
• 03.11.2025 - Leerink Global Healthcare Conference 2025
• 03.10.2025 - WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.04.2025 - Raymond James 46th Annual Institutional Investors Conference
• 02.25.2025 - Ionis to present at upcoming investor conferences
• 02.20.2025 - New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control

Recent Filings

• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 8-K Current report